Selective glycopeptide profiling by acetone enrichment and LC/MS (2014)
Takakura D, Harazono A, Hashii N, Kawasaki N
Journal of Proteomics, 2014 vol.101:17-30
SNFG,
Text,
Oxford
taxonomy (1)
protein (28)
source (1)
structure (5)
composition (38)
disease (0)
reference (1)
site (51)
peptide (0)
- Homo sapiens (Human)
Taxonomy
- Alpha-1-acid glycoprotein 1 / Homo sapiens P02763
- Alpha-1-acid glycoprotein 2 / Homo sapiens P19652
- Alpha-1-antichymotrypsin / Homo sapiens P01011
- Alpha-1-antitrypsin / Homo sapiens P01009
- Alpha-2-hs-glycoprotein / Homo sapiens P02765
- Alpha-2-macroglobulin / Homo sapiens P01023
- Antithrombin-III / Homo sapiens P01008
- Apolipoprotein d / Homo sapiens P05090
- Beta-2-glycoprotein 1 / Homo sapiens P02749
- Ceruloplasmin / Homo sapiens P00450
- Clusterin / Homo sapiens P10909
- Complement c3 / Homo sapiens P01024
- Complement c4-a / Homo sapiens P0C0L4
- Complement factor b / Homo sapiens P00751
- Complement factor h / Homo sapiens P08603
- Haptoglobin / Homo sapiens P00738
- Hemopexin / Homo sapiens P02790
- Histidine-rich glycoprotein / Homo sapiens P04196
- Immunoglobulin heavy constant alpha 2 / Homo sapiens P01877
- Immunoglobulin heavy constant gamma 1 / Homo sapiens P01857
- Immunoglobulin heavy constant gamma 2 / Homo sapiens P01859
- Immunoglobulin heavy constant gamma 4 / Homo sapiens P01861
- Immunoglobulin heavy constant mu / Homo sapiens P01871
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens Q14624
- Kininogen-1 / Homo sapiens P01042
- Plasma protease c1 inhibitor / Homo sapiens P05155
- Prothrombin / Homo sapiens P00734
- Serotransferrin / Homo sapiens P02787
Protein
- Blood Serum (UBERON_0001977)
Source
- N-Linked / Complex / NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 251
- N-Linked / Complex / Structure 829
- N-Linked / Complex / Structure 2404
- N-Linked / Complex / Structure 775
Reported structure
- Hex:3 HexNAc:3 dHex:1 (avg mass : 1260.1705 )
- Hex:3 HexNAc:4 (avg mass : 1317.2225 )
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:3 HexNAc:5 (avg mass : 1520.4175 )
- Hex:3 HexNAc:5 dHex:1 (avg mass : 1666.5605 )
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1713.5708 )
- Hex:4 HexNAc:4 (avg mass : 1479.3649 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1916.7658 )
- Hex:4 HexNAc:5 (avg mass : 1682.5599 )
- Hex:4 HexNAc:5 NeuAc:1 (avg mass : 1973.8178 )
- Hex:4 HexNAc:5 dHex:1 (avg mass : 1828.7029 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:5 (avg mass : 1844.7023 )
- Hex:5 HexNAc:5 NeuAc:1 (avg mass : 2135.9602 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:7 HexNAc:6 NeuAc:2 (avg mass : 2954.6979 )
- Hex:7 HexNAc:6 NeuAc:3 (avg mass : 3245.9558 )
- Hex:7 HexNAc:6 NeuAc:4 (avg mass : 3537.2137 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3100.8409 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3392.0988 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 (avg mass : 3683.3567 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
Composition
Disease
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-hs-glycoprotein / Homo sapiens
- Alpha-2-macroglobulin / Homo sapiens
- Antithrombin-III / Homo sapiens
- Apolipoprotein d / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Clusterin / Homo sapiens
- Complement c3 / Homo sapiens
- Complement c4-a / Homo sapiens
- Complement factor b / Homo sapiens
- Complement factor h / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Histidine-rich glycoprotein / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 4 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
- Kininogen-1 / Homo sapiens
- Plasma protease c1 inhibitor / Homo sapiens
- Prothrombin / Homo sapiens
- Serotransferrin / Homo sapiens
Reported glycosite
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 2224.0231)
- Blood Serum (UBERON_0001977)
- Alpha-1-acid glycoprotein 1 / Homo sapiens
-
- N-Linked / Complex (avg mass : 2880.6184)
- Blood Serum (UBERON_0001977)
- Alpha-1-acid glycoprotein 1 / Homo sapiens
-
- N-Linked / Complex (avg mass : 2954.6979)
- Blood Serum (UBERON_0001977)
- Alpha-1-acid glycoprotein 1 / Homo sapiens
-
- N-Linked / Complex (avg mass : 3245.9558)
- Blood Serum (UBERON_0001977)
- Alpha-1-acid glycoprotein 1 / Homo sapiens
-
- N-Linked / Complex (avg mass : 3537.2137)
- Blood Serum (UBERON_0001977)
- Alpha-1-acid glycoprotein 1 / Homo sapiens
-
- Hex:5 HexNAc:2 / N-Linked (avg mass : 1235.1173)
- Blood Serum (UBERON_0001977)
- Complement c3 / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
-
- Hex:3 HexNAc:3 dHex:1 / N-Linked (avg mass : 1260.1705)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
-
- Hex:3 HexNAc:4 / N-Linked (avg mass : 1317.2225)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
-
- Hex:6 HexNAc:2 / N-Linked (avg mass : 1397.2597)
- Blood Serum (UBERON_0001977)
- Complement c3 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
-
- Hex:3 HexNAc:4 dHex:1 / N-Linked (avg mass : 1463.3655)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 4 / Homo sapiens
-
- Hex:4 HexNAc:4 / N-Linked (avg mass : 1479.3649)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
-
- Hex:3 HexNAc:5 / N-Linked (avg mass : 1520.4175)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
-
- Hex:7 HexNAc:2 / N-Linked (avg mass : 1559.4021)
- Blood Serum (UBERON_0001977)
- Complement c3 / Homo sapiens
-
- Hex:4 HexNAc:4 dHex:1 / N-Linked (avg mass : 1625.5079)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 4 / Homo sapiens
-
- Hex:5 HexNAc:4 / N-Linked (avg mass : 1641.5073)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
-
- Hex:3 HexNAc:5 dHex:1 / N-Linked (avg mass : 1666.5605)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
-
- Hex:4 HexNAc:5 / N-Linked (avg mass : 1682.5599)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
-
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 / N-Linked (avg mass : 1713.5708)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant mu / Homo sapiens
-
- Hex:8 HexNAc:2 / N-Linked (avg mass : 1721.5445)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant mu / Homo sapiens
-
- Hex:5 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1729.5702)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
-
- Hex:5 HexNAc:4 dHex:1 / N-Linked (avg mass : 1787.6503)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 4 / Homo sapiens
-
- Hex:4 HexNAc:5 dHex:1 / N-Linked (avg mass : 1828.7029)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 2 / Homo sapiens
-
- Hex:5 HexNAc:5 / N-Linked (avg mass : 1844.7023)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
-
- Hex:9 HexNAc:2 / N-Linked (avg mass : 1883.6869)
- Blood Serum (UBERON_0001977)
- Complement c4-a / Homo sapiens
-
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 1916.7658)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 4 / Homo sapiens
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1932.7652)
- Blood Serum (UBERON_0001977)
- Alpha-2-macroglobulin / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Histidine-rich glycoprotein / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Prothrombin / Homo sapiens
-
- Hex:4 HexNAc:5 NeuAc:1 / N-Linked (avg mass : 1973.8178)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 4 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
-
- Hex:5 HexNAc:5 NeuAc:1 / N-Linked (avg mass : 2135.9602)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Blood Serum (UBERON_0001977)
- N-Linked / Complex / NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-hs-glycoprotein / Homo sapiens
- Alpha-2-macroglobulin / Homo sapiens
- Antithrombin-III / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Clusterin / Homo sapiens
- Complement c4-a / Homo sapiens
- Complement factor b / Homo sapiens
- Complement factor h / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Histidine-rich glycoprotein / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
- Kininogen-1 / Homo sapiens
- Plasma protease c1 inhibitor / Homo sapiens
- Prothrombin / Homo sapiens
- Serotransferrin / Homo sapiens
-
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2282.1032)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
-
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked (avg mass : 2298.1026)
- Blood Serum (UBERON_0001977)
- Haptoglobin / Homo sapiens
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked (avg mass : 2370.1661)
- Blood Serum (UBERON_0001977)
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-macroglobulin / Homo sapiens
- Apolipoprotein d / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Hemopexin / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Serotransferrin / Homo sapiens
-
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked (avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
- Alpha-1-antichymotrypsin / Homo sapiens
- Haptoglobin / Homo sapiens
- Plasma protease c1 inhibitor / Homo sapiens
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 / N-Linked (avg mass : 2735.5035)
- Blood Serum (UBERON_0001977)
- Alpha-1-antichymotrypsin / Homo sapiens
- Plasma protease c1 inhibitor / Homo sapiens
-
- Hex:6 HexNAc:5 NeuAc:3 / N-Linked (avg mass : 2880.6184)
- Blood Serum (UBERON_0001977)
- N-Linked / Complex / Structure 251
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Clusterin / Homo sapiens
- Haptoglobin / Homo sapiens
- Kininogen-1 / Homo sapiens
-
- Hex:7 HexNAc:6 NeuAc:2 / N-Linked (avg mass : 2954.6979)
- Blood Serum (UBERON_0001977)
- N-Linked / Complex / Structure 829
- Alpha-1-acid glycoprotein 1 / Homo sapiens
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked (avg mass : 3026.7614)
- Blood Serum (UBERON_0001977)
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Clusterin / Homo sapiens
- Haptoglobin / Homo sapiens
- Kininogen-1 / Homo sapiens
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 3100.8409)
- Blood Serum (UBERON_0001977)
- Alpha-1-acid glycoprotein 1 / Homo sapiens
-
- Hex:7 HexNAc:6 NeuAc:3 / N-Linked (avg mass : 3245.9558)
- Blood Serum (UBERON_0001977)
- N-Linked / Complex / Structure 2404
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 / N-Linked (avg mass : 3392.0988)
- Blood Serum (UBERON_0001977)
- Alpha-1-acid glycoprotein 1 / Homo sapiens
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 / N-Linked (avg mass : 3683.3567)
- Blood Serum (UBERON_0001977)
- Alpha-1-antichymotrypsin / Homo sapiens
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
